New York State Common Retirement Fund An2 Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$5.06 - $9.91 $29,236 - $57,259	-5,778 Reduced 98.28%	101 $1,000
Q1 2023 May 02, 2023	BUY	$7.94 - $15.6 $428 - $842	54 Added 0.93%	5,879 $58,000
Q3 2022 Nov 08, 2022	SELL	$7.61 - $22.29 $42,425 - $124,266	-5,575 Reduced 48.9%	5,825 $101,000
Q2 2022 Aug 04, 2022	BUY	$7.7 - $18.82 $87,780 - $214,548	11,400 New	11,400 $88,000

13.5M

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $26M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.